Quots for Milbemycin Oxime Dog - Sulfadoxine+pyrimethamine tablets – KeMing Medicines Detail:
FOB Price | Inquiry |
Min.Order Quantity | 1,000,000 tablets |
Supply Ability | 120,000,000 tablets/Month |
Port | Shanghai |
Payment Terms | T/T in advance |
Product Detail | |
Product name | Sulfadoxine+pyrimethamine tablets |
Specification | 500mg+25mg |
Description | A white tablets |
Standard | USP |
Package | 3tablets/box |
Transportation | Ocean,Land,Air |
Certificate | GMP |
Price | Inquiry |
Quality guaranteeperiod | for 36 months |
Product Description | [Indications]:Treatment of plasmodium falciparum malaria especially in
patients and in areas where P falciparum malaria resistant to chloroquine is suspected. 9-14 years:2 tabs,4-8 years:1 tab,<4 years:1/2tab Ail doses are to be taken once daily.Malaria Prophylaxis:The first dose of FANS-MINE should be taken 1 or 2 weeks before departure to n endemic area,administration should be continued during the stay and for 4-6 weeks after return. |
Product detail pictures:
Related Product Guide:
Medication & Dietary Supplement Interactions – What You Should Know about Drugs and Vitamins
Prescription Drugs Can Lead to Vitamin and Mineral Deficiencies
We keep on with our enterprise spirit of "Quality, Efficiency, Innovation and Integrity". We intention to create extra worth for our buyers with our prosperous resources, superior machinery, experienced workers and superb services for Quots for Milbemycin Oxime Dog - Sulfadoxine+pyrimethamine tablets – KeMing Medicines, The product will supply to all over the world, such as: Salt Lake City, Angola, Italy, We will do our utmost to cooperate & satisfied with you relying on top-grade quality and competitive price and best after service ,sincerely look forward to cooperating with you and make achievements in the future!
By Jerry from Orlando - 2018.07.12 12:19
This manufacturer can keep improving and perfecting products and service, it is in line with the rules of market competition, a competitive company.
By Nicole from Switzerland - 2017.04.28 15:45